Stocktoria
Alaunos Therapeutics, Inc. TCRT
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2004-08-20
Alaunos Therapeutics, Inc. statistics & valuation
Market cap$5.1M
P / B2.4×
Net margin-83520.0%
Return on equity-194.0%
FCF margin-59340.0%
Return on capital-196.2%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -84500.0% | -48120.0% | -685340.0% | -1201.4% | -19484.7% | — | — | -36921.9% | -336.4% | -2409.4% |
| Net margin | -83520.0% | -46790.0% | -93580.0% | -1291.2% | -19786.7% | — | — | -36381.5% | -341.7% | -2409.2% |
| FCF margin | -59340.0% | -49710.0% | -606780.0% | -1007.8% | -16279.1% | — | — | -34189.0% | -348.5% | -858.1% |
| Return on assets | -140.8% | -169.8% | -56.6% | -58.1% | -83.0% | -54.6% | -108.0% | -55.9% | -51.4% | -155.4% |
| Return on equity | -194.0% | -226.8% | -74.2% | -97.9% | -135.6% | -64.5% | -124.0% | -62.1% | 56.1% | 213.8% |
| Debt / equity | — | 0.00× | 0.00× | 0.00× | 0.28× | 0.00× | — | — | — | — |
| Current ratio | 2.45 | 3.98 | 4.22 | 2.23 | 4.91 | 7.11 | 8.42 | 8.89 | 4.35 | 6.63 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.